atracurium has been researched along with phenytoin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Diaz, J; Matteo, RS; Ornstein, E; Schwartz, AE; Silverberg, PA; Young, WL | 1 |
| Bevan, JC; Hickey, DR; Sangwan, S | 1 |
| Bickler, PE; Cardone, C; Szenohradszky, J; Yost, S | 1 |
| Boudreault, D; Bouthilier, A; Chouinard, P; Couture, J; Girard, DC; Girard, F; Moumdjian, R; Richard, A; Ruel, M; Varin, F | 1 |
1 review(s) available for atracurium and phenytoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for atracurium and phenytoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.
Topics: Adult; Anesthesia; Atracurium; Dose-Response Relationship, Drug; Drug Interactions; Electromyography; Female; Halothane; Humans; Male; Neuromuscular Blocking Agents; Neuromuscular Junction; Phenytoin; Vecuronium Bromide | 1987 |
Phenytoin-induced resistance to pancuronium. Use of atracurium infusion in management of a neurosurgical patient.
Topics: Adolescent; Atracurium; Brain Neoplasms; Drug Interactions; Drug Tolerance; Epilepsy; Humans; Infusions, Intravenous; Male; Pancuronium; Parietal Lobe; Phenytoin | 1988 |
Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity.
Topics: Acetylcholine; Anesthesia, General; Animals; Atracurium; Brain; Calcium; Convulsants; Dose-Response Relationship, Drug; Enflurane; Female; Glutamates; Glutamic Acid; In Vitro Techniques; Isoquinolines; Kainic Acid; Male; N-Methylaspartate; Neuromuscular Nondepolarizing Agents; Neurotoxins; Nicotine; Pancuronium; Phenytoin; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Time Factors; Tubocurarine; Vecuronium Bromide | 1994 |
Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Anticonvulsants; Atracurium; Carbamazepine; Chromatography, High Pressure Liquid; Drug Interactions; Electric Stimulation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Monitoring, Intraoperative; Nerve Block; Neuromuscular Nondepolarizing Agents; Neurosurgical Procedures; Phenytoin; Synaptic Transmission | 2005 |